dockets: FDA-2019-P-6099
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-P-6099 | FDA | Requests that the FDA pursue enforcement action, if the FDA has not already done so against Bayer U.S., as subsidiary of Bayer AG the will prevent the reoccurrence of its mislabeling nearly 1,000 vials of hemophilia A treatment Kogenate FS, improper storage of hemophilia treatment products and release of expired hemophilia treatment products to the US consumer market. CLOSED | Nonrulemaking | 2021-08-27T15:13:06Z | 0b0000648425e10a | FDA-2019-P-6099 | ["CLOSED", "Citizen Petition", "CBER", "Patients for Access to Advanced Therapy", "for Hemophilia", "pursue enforcement action", "if the FDA has not already done so", "against Bayer U.S., as subsidiary of", "that will prevent the reoccurrence of", "its mislabeling nearly 1,000 vials of", "hemophilia A treatment Kogenate FS", "improper storage of hemophilia treatment", "products and release of expired", "hemophilia treatment products to the", "US consumer market"] | CBER | Requests that the FDA pursue enforcement action, if the FDA has not already done so against Bayer U.S., as subsidiary of Bayer AG. | {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["CLOSED", "Citizen Petition", "CBER", "Patients for Access to Advanced Therapy", "for Hemophilia", "pursue enforcement action", "if the FDA has not already done so", "against Bayer U.S., as subsidiary of", "that will prevent the reoccurrence of", "its mislabeling nearly 1,000 vials of", "hemophilia A treatment Kogenate FS", "improper storage of hemophilia treatment", "products and release of expired", "hemophilia treatment products to the", "US consumer market"], "modifyDate": "2021-08-27T15:13:06Z", "dkAbstract": "FDA-2019-P-6099", "agencyId": "FDA", "program": "CBER", "shortTitle": "Requests that the FDA pursue enforcement action, if the FDA has not already done so against Bayer U.S., as subsidiary of Bayer AG.", "subType2": null, "title": "Requests that the FDA pursue enforcement action, if the FDA has not already done so against Bayer U.S., as subsidiary of Bayer AG the will prevent the reoccurrence of its mislabeling nearly 1,000 vials of hemophilia A treatment Kogenate FS, improper storage of hemophilia treatment products and release of expired hemophilia treatment products to the US consumer market.\nCLOSED", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "CLOSED", "effectiveDate": null, "objectId": "0b0000648425e10a"} | single_get |
Links from other tables
- 5 rows from docket_id in documents